Similar articles for PMID: 27726834

Year	Number of Results
1990	1
1992	2
1993	1
1995	1
1996	1
1997	1
2000	2
2002	1
2003	2
2004	3
2005	4
2006	8
2007	4
2008	6
2009	2
2010	1
2011	4
2012	6
2013	2
2014	2
2015	4
2016	4
2017	6
2018	5
2019	13
2020	5
2021	1
2022	2

1

Correction: Anemia of chronic kidney disease.

Simon JF, Nakhoul G. Simon JF, et al. Cleve Clin J Med. 2016 Oct;83(10):739. Cleve Clin J Med. 2016. PMID: 27726834 Free article.

2

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T. Tsubakihara Y, et al. Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x. Ther Apher Dial. 2010. PMID: 20609178

3

Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?

Dukkipati R, Kalantar-Zadeh K. Dukkipati R, et al. Nephrol News Issues. 2007 Jan;21(1):34-8. Nephrol News Issues. 2007. PMID: 17269263 Review.

4

Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.

Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H. Nakamura T, et al. Am J Nephrol. 2006;26(3):276-80. doi: 10.1159/000093934. Epub 2006 Jun 13. Am J Nephrol. 2006. PMID: 16772708 Clinical Trial.

5

Correction: Men's health 2018.

Chaitoff A, Killeen TC, Nielsen C. Chaitoff A, et al. Cleve Clin J Med. 2018 Dec;85(12):913. Cleve Clin J Med. 2018. PMID: 30526762 Free article.

6

Triumph and tragedy: anemia management in chronic kidney disease.

Novak JE, Szczech LA. Novak JE, et al. Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. doi: 10.1097/MNH.0b013e32830c488d. Curr Opin Nephrol Hypertens. 2008. PMID: 18941350 Review.

7

Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.

Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F; Anemia Correction in Diabetes Study Investigators. Ritz E, et al. Am J Kidney Dis. 2007 Feb;49(2):194-207. doi: 10.1053/j.ajkd.2006.11.032. Am J Kidney Dis. 2007. PMID: 17261422 Clinical Trial.

8

Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis.

Charytan C, Qunibi W, Bailie GR; Venofer Clinical Studies Group. Charytan C, et al. Nephron Clin Pract. 2005;100(3):c55-62. doi: 10.1159/000085049. Epub 2005 Apr 11. Nephron Clin Pract. 2005. PMID: 15824508 Clinical Trial.

9

[Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].

Oliveira C, Boquinhas H, Gaspar A, Adragão T, Boquinhas JM, Júnior EC, Simões J. Oliveira C, et al. Acta Med Port. 1992 Jul;5(7):351-7. Acta Med Port. 1992. PMID: 1442178 Free article. Clinical Trial. Portuguese.

10

A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.

Block GA, Fishbane S, Rodriguez M, Smits G, Shemesh S, Pergola PE, Wolf M, Chertow GM. Block GA, et al. Am J Kidney Dis. 2015 May;65(5):728-36. doi: 10.1053/j.ajkd.2014.10.014. Epub 2014 Nov 4. Am J Kidney Dis. 2015. PMID: 25468387 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed